Cedars-Sinai Guerin Children’s announced Thursday the launch of a new asthma-monitoring program using a wearable smart stethoscope designed to help doctors remotely track breathing problems in pediatric patients between clinic visits.
The device, known as AeviceMD, allows clinicians to monitor children’s lung sounds in real time and identify early signs of worsening asthma symptoms, according to Cedars-Sinai officials.
“Being able to assess respiratory symptoms in real time, especially overnight, provides valuable information that can guide earlier intervention and help prevent more serious breathing complications,” Dr. Irina Dralyuk, a pediatric pulmonologist at Guerin Children’s, said in a statement.
Officials said the wearable device, about the size of a half-dollar coin, is intended for children age 3 and older and can be worn on the chest for up to 10 hours a day. Parents can use the device at home to record lung sounds and securely share the data with physicians.
The technology is designed to give doctors a clearer picture of how asthma symptoms change between office visits and how children respond to treatment plans.
Asthma affects roughly 4.5 million children in the United States and is one of the nation’s most common chronic childhood diseases.
“What we’re trying to do is prevent exacerbations, reduce hospitalizations and emergency department visits, and limit the need for interventions such as systemic steroid use to control asthma symptoms,” Dralyuk said. “Intervening early could decrease chronic inflammation and improve lung function and health over time.”
The device was developed by Singapore-based Aevice Health, a graduate of the Cedars-Sinai Accelerator program. Cedars-Sinai officials said the collaboration began in 2022 and included clinical testing and regulatory review before the device received clearance from the U.S. Food and Drug Administration in 2023.
“It’s an exciting example of how innovation can directly impact care and improve the way we manage chronic conditions like asthma,” said Nirdesh K. Gupta, managing partner of Cedars-Sinai Intellectual Property Company.